In silico investigation of ADAM12 effect on TGF-beta receptors trafficking

Jérémy Gruel1, Michel Leborgne, Nolwenn LeMeur

  • 1EA 4427 SeRAIC/INSERM U620, Université de Rennes 1, Rennes, France. gruelj@gmail.com

BMC Research Notes
|September 26, 2009
PubMed
Abstract

Insights

The disintegrin and metalloproteinase ADAM12 enhances transforming growth factor beta (TGF-β) receptor internalization and signaling. This modulation favors a sustained cellular response, impacting liver fibrosis development.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Systems Biology

Background:

  • Transforming growth factor beta (TGF-β) exhibits diverse cellular effects, but mechanisms are unclear.
  • TGF-β signaling is context-dependent and influenced by protein interactions.
  • ADAM12 interacts with TGF-β receptors, affecting their trafficking and liver fibrosis.

Purpose of the Study:

  • To elucidate the impact of ADAM12 on TGF-β receptor trafficking.
  • To understand how ADAM12 influences TGF-β signaling pathways.

Main Methods:

  • Qualitative biological observations from experimental data.
  • Computational modeling and analysis of biological systems.
  • Differential modeling confronted with biological data.

Main Results:

  • ADAM12 accelerates TGF-β receptor internalization between cell surface and endosomes.
  • ADAM12 alters TGF-β signaling, promoting a sustained response by reducing transient signaling.
  • Computational models predicted novel insights into ADAM12 function.

Conclusions:

  • Differential modeling provided new perspectives on ADAM12's role in TGF-β signaling.
  • ADAM12's modulation of TGF-β signaling is crucial for understanding hepatic fibrosis.